Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gallium-68 Labelled THP-PSMA for the Clinical Stage and Restage of Prostate Cancer Patients

NCT04158817 is registered in ClinicalTrials.gov with Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine as lead sponsor.

NCT NCT04158817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04158817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gallium-68 Labelled THP-PSMA for the Clinical Stage and Restage of Prostate Cancer Patients
Lead sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
November 1, 2019
Completion date
March 31, 2023
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer